Health Care & Life Sciences » Pharmaceuticals | CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
23.70
47.70
-
-
1,670.90
Cost of Goods Sold (COGS) incl. D&A
17.40
55.60
74.70
66.50
117.80
1,670.90
Gross Income
17.40
31.90
26.90
66.50
117.80
1,670.90
SG&A Expense
5,722.60
6,473.90
7,125.50
9,354.20
10,633.50
24,833.50
EBIT
5,740.00
6,505.80
7,152.40
9,420.60
10,751.30
26,504.50
Unusual Expense
-
19,669.90
27.50
6.80
19.90
1,007.10
Interest Expense
-
28.10
82.50
33.80
15.00
8.20
Pretax Income
5,738.40
26,202.30
7,206.40
9,453.50
10,770.20
27,471.60
Consolidated Net Income
5,738.40
26,202.30
7,206.40
9,453.50
10,770.20
27,471.60
Net Income
5,738.40
26,202.30
7,206.40
9,453.50
10,770.20
27,471.60
Net Income After Extraordinaries
5,738.40
26,202.30
7,206.40
9,453.50
10,770.20
27,471.60
Net Income Available to Common
5,738.40
26,202.30
7,206.40
9,453.50
10,770.20
27,471.60
EPS (Basic)
0.22
0.92
0.22
0.17
0.18
0.32
Basic Shares Outstanding
26,125.90
28,595.40
32,445.80
55,869.20
61,514.00
84,752.20
EPS (Diluted)
0.22
0.92
0.22
0.17
0.18
0.32
Diluted Shares Outstanding
26,125.90
28,595.40
32,445.80
55,869.20
61,514.00
84,752.20
EBITDA
5,722.60
6,457.60
7,084.00
9,354.20
10,633.50
24,833.50
Non-Operating Interest Income
1.70
1.50
0.90
7.70
16.00
48.20

About CASI Pharmaceuticals

View Profile
Address
9620 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.casipharmaceuticals.com
Updated 07/08/2019
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The firm develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.